ETTX NASDAQ
Entasis Therapeutics Holdings Inc.
1W: -0.5%
1M: +0.5%
3M: +18.4%
1Y: -11.3%
3Y: -65.5%
$2.19
Last traded 2022-07-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-87M
Net Income
-89.1% YoY
$-47M
Free Cash Flow
-11.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-285.2%
ROA-179.2%
ROIC-3610.1%
Valuation
P/E-2.2
P/B3.3
EV/EBITDA-0.9
Leverage
Debt/Equity1.13
Current Ratio1.65
Interest Cov.-6239.3x
Quality Scores
Piotroski F1/9
Altman Z-10.12
Beneish M0.00